Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)
Completed
Conditions studied: Eosinophilic Esophagitis
In brief
This study is aimed at understanding whether oral nitric oxide levels can be used as a non-invasive marker for the diagnosis and management of patient with eosinophilic esophagitis (EoE).
Key facts
- Study ID
- NCT01929824
- Run by
- Mayo Clinic
- People needed
- 50
- Starts
- 2013-08-01
- Expected to finish
- 2019-09-25
- Last updated by the study team
- 2019-09-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects with dysphagia and active esophageal infiltration (esophageal eosinophilic count of >/= 15 eos/hpf)
- Subjects with or without a clinical diagnosis of asthma
You may not qualify if…
- Subjects with chronic cough
- Severe CAD
- MI within the last 3 months
- Cystic fibrosis
- Tuberculosis
- Chronic obstructive pulmonary disease (COPD)
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.